Your browser doesn't support javascript.
loading
Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study.
Tufail, A; Patel, P J; Sivaprasad, S; Amoaku, W; Browning, A C; Cole, M; Gale, R; George, S; Lotery, A J; Majid, M; McKibbin, M; Menon, G; Yang, Y; Andrews, C; Brittain, C; Osborne, A.
Affiliation
  • Tufail A; Moorfields Eye Hospital, London, UK. Adnan.Tufail@moorfields.nhs.uk
Eye (Lond) ; 27(6): 709-15, 2013 Jun.
Article in En | MEDLINE | ID: mdl-23449508
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Choroidal Neovascularization / Angiogenesis Inhibitors / Antibodies, Monoclonal, Humanized / Myopia Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eye (Lond) Journal subject: OFTALMOLOGIA Year: 2013 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Choroidal Neovascularization / Angiogenesis Inhibitors / Antibodies, Monoclonal, Humanized / Myopia Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eye (Lond) Journal subject: OFTALMOLOGIA Year: 2013 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido